NCT03436953View on ClinicalTrials.gov

A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

December 31, 2020

Conditions
Parkinson's DiseaseTremor
Interventions
DRUG

CX-8998

T-type calcium channel blocker

DRUG

Placebo

Placebo comparator

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY